Multicenter, Randomized, Double-Blind Study of Ceftobiprole [medocaril] Versus Comparators in the Treatment of Patients With Fever and Neutropenia.
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Ceftobiprole medocaril (Primary) ; Cefepime; Vancomycin
- Indications Bacterial infections; Febrile neutropenia
- Focus Registrational; Therapeutic Use
- Sponsors Basilea Pharmaceutica; Janssen Research & Development
- 07 Aug 2012 Additional trial locations (Belgium and Hungery), Janssen-Cilag as sponsor and lead trial centre added as reported by European Clinical Trials Database record.
- 31 Jul 2012 Company (Basilea Pharmaceutica) added as an association and lead cantre as reported by ClinicalTrials.gov.
- 31 Jul 2012 Actual end date (1 Jan 2008) added as reported by ClinicalTrials.gov.